TheraGlio - developing theranostics for gliomas.

Nanomol Technologies SA
nanomol@theraglio.eu

NANOMOL TECHNOLOGIES SA (NANOMOL) is a spin-off company of a research group in Institute de Ciència de Materials de Barcelona of CSIC (Spanich Research Council). NANOMOL TECHNOLOGIES was founded at the end of 2010 as a science and innovation driven company providing cutting edge solutions to process and structure, at micro and nanoscale, active molecules of pharma, biotech, cosmetic and chemical companies. Its mission is to generate revolutionary nanomaterias, nanomedicines, drug delivery systems with outstanding therapeutic efficacy and patient’s compliance. NANOMOL TECHNOLOGIES has strong expertise to develop, apply, scale-up and industrialize new technologies based on the use of compressed fluids or supercritical fluids for preparing micro and nanoparticulate materials in one single process step.

Main tasks attributed to the organisation: Design and characterization of new lipid shelled microbubbles for multimodality imaging and drug delivery carrier. Definition of specifications a fabrication prototype to be produced under GMP conditions.